These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32031658)

  • 1. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Suárez-Díaz S; Mozo L; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Jul; 59(7):1752-1764. PubMed ID: 32031658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
    Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
    PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.
    Ammirati E; Bozzolo EP; Contri R; Baragetti A; Palini AG; Cianflone D; Banfi M; Uboldi P; Bottoni G; Scotti I; Pirillo A; Grigore L; Garlaschelli K; Monaco C; Catapano AL; Sabbadini MG; Manfredi AA; Norata GD
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):751-9. PubMed ID: 24787906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mikołajczyk TP; Osmenda G; Batko B; Wilk G; Krezelok M; Skiba D; Sliwa T; Pryjma JR; Guzik TJ
    Lupus; 2016 Jan; 25(1):18-27. PubMed ID: 26251402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
    J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.
    Bortoluzzi A; Chighizola CB; Fredi M; Raschi E; Bodio C; Privitera D; Gonelli A; Silvagni E; Govoni M; Cavazzana I; Airò P; Meroni PL; Tincani A; Franceschini F; Piantoni S; Casciano F
    Front Immunol; 2020; 11():572876. PubMed ID: 33193356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.
    Rahman S; Sagar D; Hanna RN; Lightfoot YL; Mistry P; Smith CK; Manna Z; Hasni S; Siegel RM; Sanjuan MA; Kolbeck R; Kaplan MJ; Casey KA
    Ann Rheum Dis; 2019 Jul; 78(7):957-966. PubMed ID: 31040119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suárez A
    Int J Cardiol; 2017 Jun; 236():138-144. PubMed ID: 28279502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein net charge is a risk factor for atherosclerosis in lupus patients independent of lipid concentrations.
    Rodríguez M; Guardiola M; Oliva I; Carles Vallvé J; Ferré R; Masana L; Parra S; Ribalta J; Castro A
    Int J Rheum Dis; 2019 Mar; 22(3):480-487. PubMed ID: 30450745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years.
    Ajeganova S; Hafström I; Frostegård J
    Lupus Sci Med; 2021 Feb; 8(1):. PubMed ID: 33547230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density.
    Rodríguez-Carrio J; Martínez-Zapico A; Cabezas-Rodríguez I; Benavente L; Pérez-Álvarez ÁI; López P; Cannata-Andía JB; Naves-Díaz M; Suárez A
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):135-143. PubMed ID: 30559042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.
    Carbone F; Dallegri F; Montecucco F; Poggi A; Nobili FM; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
    Eur J Clin Invest; 2019 May; 49(5):e13089. PubMed ID: 30767212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.
    Garcia-Garcia P; Castejon R; Tutor-Ureta P; Silvestre RA; Mellor-Pita S; Jimenez-Ortiz C; Yebra-Bango M
    Clin Rheumatol; 2017 Dec; 36(12):2709-2717. PubMed ID: 28914371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
    Burbano C; Vasquez G; Rojas M
    Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of monocyte to high-density lipoprotein cholesterol ratio with carotid artery intima-media thickness in patients with systemic lupus erythematosus.
    Wang Q; Meng Y; Cao W; Du W; Liu Y; Yan Y; Luo L; Ma X
    Biomark Med; 2018 Apr; 12(4):359-364. PubMed ID: 29569475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of CD16- monocyte subsets in systemic lupus erythematous patients.
    Wu Z; Zhang S; Zhao L; Fei Y; Wang L; Li J; Wen X; Zeng X; Zhang F; Li Y
    Clin Rheumatol; 2017 Oct; 36(10):2281-2287. PubMed ID: 28821990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.